Morris Madeline A, Jacobson Sean R, Kinney Gregory L, Tashkin Donald P, Woodruff Prescott G, Hoffman Eric A, Kanner Richard E, Cooper Christopher B, Drummond M Brad, Barr R Graham, Oelsner Elizabeth C, Make Barry J, Han MeiLan K, Hansel Nadia N, O'Neal Wanda K, Bowler Russell P
1-National Jewish Health, Denver, Colorado.
2-Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
Chronic Obstr Pulm Dis. 2018 Jan 24;5(1):46-56. doi: 10.15326/jcopdf.5.1.2017.0141.
Marijuana is often smoked via a filterless cigarette and contains similar chemical makeup as smoked tobacco. There are few publications describing usage patterns and respiratory risks in older adults or in those with chronic obstructive pulmonary disease (COPD). A cross-sectional analysis of current and former tobacco smokers from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) study assessed associations between marijuana use and pulmonary outcomes. Marijuana use was defined as never, former (use over 30 days ago), or current (use within 30 days). Respiratory health was assessed using quantitative high-resolution computed tomography (HRCT) scans, pulmonary function tests and questionnaire responses about respiratory symptoms. Of the total 2304 participants, 1130 (49%) never, 982 (43%) former, and 192 (8%) current marijuana users were included. Neither current nor former marijuana use was associated with increased odds of wheeze (odds ratio [OR] 0.87, OR 0.97), cough (OR 1.22; OR 0.93) or chronic bronchitis (OR 0.87; OR 1.00) when compared to never users. Current and former marijuana users had lower quantitative emphysema (=0.004, =0.03), higher percent predicted forced expiratory volume in 1 second (FEV%) (<0.001, <0.001), and percent predicted forced vital capacity (FVC%) (<0.001, <0.001). Current marijuana users exhibited higher total tissue volume (=0.003) while former users had higher air trapping (<0.001) when compared to never marijuana users. Marijuana use was found to have little to no association with poor pulmonary health in older current and former tobacco smokers after adjusting for covariates. Higher forced expiratory volume in 1 second (FEV) and forced vital capacity (FVC) was observed among current marijuana users. However, higher joint years was associated with more chronic bronchitis symptoms (e.g., wheeze), and this study cannot determine if long-term heavy marijuana smoking in the absence of tobacco smoking is associated with lung symptoms, airflow obstruction, or emphysema, particularly in those who have never smoked tobacco cigarettes.
大麻通常通过无过滤嘴香烟吸食,其化学成分与烟草类似。很少有出版物描述老年人或慢性阻塞性肺疾病(COPD)患者的使用模式和呼吸风险。对慢性阻塞性肺疾病研究(SPIROMICS)中现吸烟者和既往吸烟者进行的横断面分析评估了大麻使用与肺部结局之间的关联。大麻使用被定义为从不使用、既往使用(30多天前使用过)或当前使用(30天内使用过)。使用定量高分辨率计算机断层扫描(HRCT)、肺功能测试以及关于呼吸道症状的问卷回答来评估呼吸健康状况。在总共2304名参与者中,1130名(49%)从不使用大麻,982名(43%)既往使用大麻,192名(8%)当前使用大麻。与从不使用者相比,当前或既往使用大麻均与喘息几率增加(优势比[OR]0.87,OR 0.97)、咳嗽(OR 1.22;OR 0.93)或慢性支气管炎(OR 0.87;OR 1.00)无关。当前和既往使用大麻者的定量肺气肿程度较低(=0.004,=0.03),1秒用力呼气容积预测值百分比(FEV%)较高(<0.001,<0.001),用力肺活量预测值百分比(FVC%)较高(<0.001,<0.001)。与从不使用大麻者相比,当前使用大麻者的总组织体积较高(=0.003),而既往使用大麻者的气体潴留较多(<0.001)。在对协变量进行调整后,发现大麻使用与当前和既往吸烟的老年人肺部健康状况不佳几乎没有关联。当前使用大麻者的1秒用力呼气容积(FEV)和用力肺活量(FVC)较高。然而,较高的联合年限与更多慢性支气管炎症状(如喘息)相关,并且本研究无法确定在不吸烟的情况下长期大量吸食大麻是否与肺部症状、气流阻塞或肺气肿相关,尤其是在那些从未吸过烟草香烟的人群中。